Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| COFCapital One Financial Corp | $135.27B | 77.7× | $53.43B | +36.6% | $2.45B | $79.26B | $51.89B | Fair valued |
| NEMNEWMONT Corp | $135.32B | 16.2× | $22.67B | +21.3% | $7.09B | $9.01B | $5.08B | Fair valued |
| MFGMizuho Financial Group Inc | $136.54B | 15.4× | ¥4.5T | +38.1% | ¥1.16T | ¥62.61T | ¥21.39T | Fair valued |
| BMYBristol Myers Squibb Co | $136.79B | 14.8× | $48.19B | -0.2% | $7.05B | $8.72B | $45.05B | Fair valued |
| ULUnilever PLC | $137.91B | 21.6× | €50.5B | -3.8% | €10.01B | €3.94B | €27.36B | Fair valued |
| VRTXVertex Pharmaceuticals Inc | $139.91B | 32.1× | $12B | +8.9% | $3.95B | $6.14B | $1.98B | Overvalued |
| ATEYYAdvantest Corp | $144.41B | 53.4× | ¥163.33B | +46.0% | ¥12.95B | ¥97.57B | ¥25B | Overvalued |
| BKNGBooking Holdings Inc. | $145.82B | 21.5× | $26.92B | +13.4% | — | $17.21B | $20.69B | Fair valued |
| DHRDanaher Corp | $146.09B | 36.9× | $24.57B | +2.9% | $3.61B | $4.35B | $27.86B | Overvalued |
| TJXTjx Companies Inc | $146.15B | 24.6× | $60.37B | +7.1% | $5.49B | $6B | $14.32B | Overvalued |
| NOWServiceNow, Inc. | $146.17B | 88.3× | $13.28B | +20.9% | $1.75B | $2.5B | $8.45B | Fair valued |
| SONYSony Group Corp | $148.01B | — | ¥12.96T | -0.5% | ¥1.16T | ¥2.98T | ¥2.95T | Fair valued |
| UBERUber Technologies, Inc | $153.94B | 16.6× | $52.02B | +18.3% | $10.05B | $4.87B | $14.73B | Fair valued |
| CILJFChina Life Insurance Co Ltd | $154B | 3.1× | CN¥804.39B | -2.5% | CN¥33.51B | CN¥127.59B | CN¥1.57B | Undervalued |
| HTHIYHitachi Ltd | $155.21B | 30.1× | ¥9.32T | +3.9% | ¥238.87B | ¥554.81B | ¥2.14T | Overvalued |
| IBKRInteractive Brokers Group, Inc. | $157.37B | 36.8× | $6.21B | +19.7% | $4.36B | $7.71B | $143M | Fair valued |
| ETNEaton Corp plc | $158.35B | 41.5× | $27.45B | +10.3% | $4.09B | $483M | $21.32B | Overvalued |
| BUDAnheuser-Busch InBev SA/NV | $158.8B | 17.3× | $59.32B | -0.7% | $8.48B | $11.64B | $73.01B | Fair valued |
| COPConocophillips | $161.78B | 17.8× | $51.82B | +4.9% | $7.99B | $6.57B | $23.3B | Overvalued |
| PFEPfizer Inc | $163.21B | 37.9× | $62.58B | -1.6% | $7.77B | $976M | $63.19B | Fair valued |